EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TLR2 is non-redundant in the population and subpopulation responses to Mycobacterium tuberculosis in macrophages and in vivo

Charul Jani, Sydney L Solomon, Joshua M Peters, Stephanie C Pringle, Amelia E Hinman, Julie Boucau, Bryan D Bryson iD, Amy K Barczak iD

mSystems · 2023

DOI: 10.1128/msystems.00052-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, 2023. Verfasst von Charul Jani und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Ragon Institute of MGH, MIT, and Harvard , Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Macrophages, Tuberculosis, Toll-Like Receptor 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health, Ragon Institute of MGH, MIT and Harvard.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB), caused by the pathogenic bacterium Mycobacterium tuberculosis (Mtb), is a global health threat. Targeting host pathways that modulate protective or harmful components of inflammation has been proposed as a therapeutic strategy that could aid sterilization or mitigate TB-associated permanent tissue damage. In purified form, many Mtb components can activate innate immune pathways. However, knowledge of the pathways that contribute most to the observed response to live Mtb is incomplete, limiting the possibility of precise intervention. We took a systematic, unbiased approach to define the pathways that drive the earliest immune response to Mtb. Using a macrophage model of infection, we compared the bulk transcriptional response to infection with the response to a panel of Mtb-derived putative innate immune ligands. We identified two axes of response: an NF-kB-dependent response similarly elicited by all Mtb pathogen-associated molecular patterns (PAMPs) and a type I interferon axis unique to cells infected with live Mtb. Consistent with growing literature data pointing to TLR2 as a dominant Mtb-associated PAMP, the TLR2 ligand PIM6 most closely approximated the NF-kB-dependent response to the intact bacterium. Quantitatively, the macrophage response to Mtb was slower and weaker than the response to purified PIM6. On a subpopulation level, the TLR2-dependent response was heterogeneously induced, with only a subset of infected cells expressing key inflammatory genes known to contribute to the control of infection. Despite potential redundancies in Mtb ligand/innate immune receptor interactions during in vivo infection, loss of the TLR2/PIM6 interaction impacted the cellular composition of both the innate and adaptive compartments. IMPORTANCE Tuberculosis (TB) is a leading cause of death globally. Drug resistance is outpacing new antibiotic discovery, and even after successful treatment, individuals are often left with permanent lung damage from the negative consequences of inflammation. Targeting host inflammatory pathways has been proposed as an approach that could either improve sterilization or improve post-treatment lung health. However, our understanding of the inflammatory pathways triggered by Mycobacterium tuberculosis (Mtb) in infected cells and lungs is incomplete, in part because of the complex array of potential molecular interactions between bacterium and host. Here, we take an unbiased approach to identify the pathways most central to the host response to Mtb. We examine how individual pathways are triggered differently by purified Mtb products or infection with the live bacterium and consider how these pathways inform the emergence of subpopulation responses in cell culture and in infected mice. Understanding how individual interactions and immune pathways contribute to inflammation in TB opens the door to the possibility of developing precise therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisMacrophagesTuberculosisToll-Like Receptor 2Host-Pathogen InteractionsCells, CulturedAnimalsMicePathogen-Associated Molecular Pattern MoleculesInterferon Type IMicrobial ViabilityNF-kappa BCellular Microenvironment

Stichwörter der Autor:innen

Mycobacterium tuberculosisTLR2innate immunitymacrophagemycobacteriasingle-cell RNAseqtuberculosis

Substanzen

Pathogen-Associated Molecular Pattern MoleculesInterferon Type INF-kappa BTlr2 protein, mouseToll-Like Receptor 2

Autor:innen und Institutionen

  • The Ragon Institute of MGH, MIT, and Harvard , Cambridge, Massachusetts, USA.
  • Department of Biological Engineering, Massachusetts Institute of Technology , Cambridge, Massachusetts, USA.
  • The Division of Infectious Diseases, Massachusetts General Hospital , Boston, Massachusetts, USA.
  • Department of Medicine, Harvard Medical School , Boston, Massachusetts, USA.

ORCID-Profile: Bryan D Bryson, Amy K Barczak

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health
  • Ragon Institute of MGH, MIT and Harvard
  • Massachusetts General Hospital
  • UAB | Center for AIDS Research, University of Alabama at Birmingham

Zitieren

APA

Jani, C., Solomon, S. L., Peters, J. M., Pringle, S. C., Hinman, A. E., Boucau, J., Bryson, B. D., & Barczak, A. K. (2023). TLR2 is non-redundant in the population and subpopulation responses to Mycobacterium tuberculosis in macrophages and in vivo. mSystems. https://doi.org/10.1128/msystems.00052-23

Vancouver

Jani C, Solomon SL, Peters JM, Pringle SC, Hinman AE, Boucau J, et al. TLR2 is non-redundant in the population and subpopulation responses to Mycobacterium tuberculosis in macrophages and in vivo. mSystems. 2023. doi:10.1128/msystems.00052-23

BibTeX
@article{Jani2023,
  author = {Jani, Charul and Solomon, Sydney L and Peters, Joshua M and Pringle, Stephanie C and Hinman, Amelia E and Boucau, Julie and Bryson, Bryan D and Barczak, Amy K},
  title = {TLR2 is non-redundant in the population and subpopulation responses to Mycobacterium tuberculosis in macrophages and in vivo},
  journal = {mSystems},
  year = {2023},
  doi = {10.1128/msystems.00052-23}
}
Kostenlos starten →